FDA BLA · BLA761034

TECENTRIQ

Sponsor: GENENTECH INC

What this page does not claim

A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.

APPLICATION
BLA761034
TYPE
BLA
ORIGINAL APPROVAL
2016-05-18
LATEST ACTION
2026-10-08
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

TECENTRIQPrescription
ATEZOLIZUMAB 1200MG/20ML · INJECTABLE · INJECTION

Approval history

2026-10-08Efficacy · Supplement 65 · priority — Letter ↗AP
2026-05-15Efficacy · Supplement 61 · priority — Letter ↗AP
2026-05-12Labeling · Supplement 62 · standard — Letter ↗AP
2025-11-17Labeling · Supplement 59 · standard — Label ↗AP
2025-10-02Efficacy · Supplement 58 · priority — Label ↗AP
2025-08-18Labeling · Supplement 57 · standard — Letter ↗AP
2024-04-22Labeling · Supplement 53 · standard — Letter ↗AP
2023-05-12Labeling · Supplement 49 · standard — Letter ↗AP
2023-05-12Labeling · Supplement 51 · standard — Letter ↗AP
2022-12-09Efficacy · Supplement 47 · priority — Label ↗AP
2022-12-02Efficacy · Supplement 50 · priority — Label ↗AP
2022-01-21Labeling · Supplement 43 · standard — Letter ↗AP
2021-10-15Efficacy · Supplement 42 · priority — Letter ↗AP
2021-10-06Efficacy · Supplement 44 · standard — Letter ↗AP
2021-04-13Efficacy · Supplement 41 · priority — Letter ↗AP
2021-02-17Efficacy · Supplement 38 · priority — Label ↗AP
2021-02-17Efficacy · Supplement 36 · priority — Label ↗AP
2021-02-17Efficacy · Supplement 34 · priority — Label ↗AP
2021-02-17Efficacy · Supplement 37 · priority — Label ↗AP
2021-02-17Efficacy · Supplement 35 · priority — Label ↗AP
2021-02-17Efficacy · Supplement 33 · priority — Label ↗AP
2020-12-18Efficacy · Supplement 32 · standard — Letter ↗AP
2020-12-18Efficacy · Supplement 31 · standard — Letter ↗AP
2020-11-10Labeling · Supplement 20 · standard — Letter ↗AP
2020-09-30Efficacy · Supplement 29 · priority — Letter ↗AP
2020-07-30Efficacy · Supplement 28 · priority — Label ↗AP
2020-05-29Efficacy · Supplement 25 · priority — Label ↗AP
2020-05-18Efficacy · Supplement 27 · priority — Label ↗AP
2019-12-03Efficacy · Supplement 21 · standard — Label ↗AP
2019-05-06Efficacy · Supplement 13 · standard — Label ↗AP
2019-05-06Efficacy · Supplement 14 · standard — Label ↗AP
2019-03-18Efficacy · Supplement 19 · priority — Label ↗AP
2019-03-08Efficacy · Supplement 18 · priority — Label ↗AP
2018-12-06Efficacy · Supplement 9 · priority — Label ↗AP
2018-07-02Efficacy · Supplement 12 · priority — Label ↗AP
2018-06-26Labeling · Supplement 11 · standard — Label ↗AP
2018-06-19Efficacy · Supplement 10 · priority — Label ↗AP
2018-06-14Efficacy · Supplement 8 · priority — Letter ↗AP
2018-04-30Efficacy · Supplement 3 · standard — Letter ↗AP
2018-03-13Labeling · Supplement 5 · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Biologics industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →